We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. The Administrator of personal data is STOCKTRADEIQ sp. z o.o., with its registered office in Poznan (61-625), at the following address: Czarna Rola 30 Street. Cookies policy here. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie
    cookieyes-consent
  • Duration
    1 year
  • Description
    CookieYes sets this cookie to remember users' consent preferences so that their preferences are respected on their subsequent visits to this site. It does not collect or store any personal information of the site visitors.
  • Cookie
    x-ms-cpim-csrf
  • Duration
    session
  • Description

    Inter-site request forgery token used to protect crSF. For more information, read the section Token falsification of requests between sites.

  • Cookie
    x-ms-cpim-sso:stocktradeiqauth.onmicrosoft.com_0
  • Duration
    session
  • Description

    Used to support single sign-on sessions. This cookie is set as persistent when the Keep me logged in option is enabled.

  • Cookie
    server-telemetry-{id}
  • Duration
    persistent
  • Description

    A value used by Microsoft for authorisation and authentication.

  • Cookie
    google_auto_fc_cmp_setting
  • Duration
    persistent
  • Description


    Stores the state of the User cookie for the current domain.

     

  • Cookie
    {id}-https://stocktradeiqauth.onmicrosoft.com/{id}
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    msal{id}.active-account
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-refreshtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-idtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    Microsoft Clarity
  • Duration
    1 year
  • Description

    Microsoft Clarity

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

  • Cookie
    isLightMode
  • Duration
    1 year
  • Description

    Defines the UI theme

  • Cookie
    userCultureData
  • Duration
    persistent
  • Description

     Stores information about the user's machine culture.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie
    _ga
  • Duration
    1 year 1 month 4 days
  • Description
    The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
  • Cookie
    _ga_*
  • Duration
    1 year 1 month 4 days
  • Description
    Google Analytics sets this cookie to store and count page views.
  • Cookie
    hotjar
  • Duration
    1 year 1 month 4 days
  • Description

    Analyzing users' behaviour in the website

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

  • Cookie
    __gpi
  • Duration
    1 year 24 days
  • Description
    Google Ads Service uses this cookie to collect information about from multiple websites for retargeting ads.
  • Cookie
    __gads
  • Duration
    1 year 24 days
  • Description

    The file, set by Google, is stored in the DoubleClick domain and tracks the number of times users view an ad, measures the success of the campaign and calculates its revenue. This cookie can only be read from the domain where it is set and does not track any data when browsing other sites.

  • Cookie
    goog:cached:topics
  • Duration
    persistent
  • Description

    It is used to record which adverts have been displayed to the User.

  • Cookie
    IDE
  • Duration
    year
  • Description

    Used by Google DoubleClick to record and report on the Website User's actions after viewing or clicking on an advertiser's ads in order to measure the effectiveness of the ad and present the User with targeted advertising.

  • Cookie
    google_experiment_mod44
  • Duration
    persistent
  • Description

    Used by Google Ad to experiment with the effectiveness of ads on websites using their services.

Powered by Cookieyes logo

    Get Diamond plan for FREE

    logo

    Allena Pharmaceuticals, Inc. (ALNA)

    Price:

    0.07 USD

    ( + 0.00 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    ALNA
    Name
    Allena Pharmaceuticals, Inc.
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    0.075
    Market Cap
    0
    Enterprise value
    -10.201M
    Currency
    USD
    Ceo
    Louis Brenner
    Full Time Employees
    12
    Website
    allenapharma.com
    Ipo Date
    2017-11-02
    City
    Newton
    Address
    1 Newton Executive Park Ste 202

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    BioNTech SE

    VALUE SCORE:

    6

    Symbol
    BNTX
    Market Cap
    22.384B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    Atara Biotherapeutics, Inc.

    VALUE SCORE:

    11

    Symbol
    ATRA
    Market Cap
    36.484M
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Harmony Biosciences Holdings, Inc.

    VALUE SCORE:

    11

    Symbol
    HRMY
    Market Cap
    1.624B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.073
    P/S
    0
    P/B
    0.129
    Debt/Equity
    0.028
    EV/FCF
    0.636
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0
    Earnings yield
    -13.681
    Debt/assets
    0.015
    FUNDAMENTALS
    Net debt/ebidta
    0.921
    Interest coverage
    -63.402
    Research And Developement To Revenue
    0
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.015
    Capex to revenue
    0
    Capex to depreciation
    1.837
    Return on tangible assets
    -0.960
    Debt to market cap
    Piotroski Score
    FUNDAMENTALS
    PEG
    -0.001
    P/CF
    -0.053
    P/FCF
    0
    RoA %
    -95.966
    RoIC %
    -166.718
    Gross Profit Margin %
    0
    Quick Ratio
    2.105
    Current Ratio
    2.105
    Net Profit Margin %
    0
    Net-Net
    0.434
    FUNDAMENTALS PER SHARE
    FCF per share
    -1.426
    Revenue per share
    0
    Net income per share
    -1.026
    Operating cash flow per share
    -1.405
    Free cash flow per share
    -1.426
    Cash per share
    0.923
    Book value per share
    0.580
    Tangible book value per share
    0.580
    Shareholders equity per share
    0.580
    Interest debt per share
    0.032
    TECHNICAL
    52 weeks high
    52 weeks low
    Current trading session High
    0.146
    Current trading session Low
    0.060
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.242

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.175

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.588
    logo
    Country
    CA
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.336
    logo
    Country
    CA
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    8.404721%
    Payout Ratio
    0%
    P/E
    -0.353

    No data to display

    logo
    Country
    CA
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.079

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    -3.2242868000000002%
    P/E
    -0.118

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.174

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.589
    DESCRIPTION

    Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.

    NEWS
    https://images.financialmodelingprep.com/news/hot-penny-stocks-to-watch-before-market-open-on-20220729.jpg
    Hot Penny Stocks to Watch Before Market Open on July 29th

    pennystocks.com

    2022-07-29 06:00:00

    Here's what you need to know about buying penny stocks on July 29th The post Hot Penny Stocks to Watch Before Market Open on July 29th  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/what-to-know-about-buying-penny-stocks-on-july-20220707.jpg
    What to Know About Buying Penny Stocks on July 7th

    pennystocks.com

    2022-07-07 07:00:00

    Here's what you need to know about trading penny stocks on July 6th The post What to Know About Buying Penny Stocks on July 7th  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/why-shares-of-allena-pharmaceuticals-are-skyrocketing-today-20220629.jpg
    Why Shares Of Allena Pharmaceuticals Are Skyrocketing Today

    benzinga.com

    2022-06-29 14:49:01

    Shares of small-cap penny stock Allena Pharmaceuticals (NASDAQ: ALNA) shares are trading higher after the company announced it has terminated its previously announced at-the-market offering. Allena Pharmaceuticals, Inc. previously entered into an At Market Issuance Sales Agreement with B.

    https://images.financialmodelingprep.com/news/alna-stock-alert-what-to-know-as-allena-pharmaceuticals-20220629.jpg
    ALNA Stock Alert: What to Know as Allena Pharmaceuticals Soars 200%

    investorplace.com

    2022-06-29 11:38:07

    Could there be an epic short squeeze going on with ALNA stock? That's the billion-dollar question as traders target Allena Pharmaceuticals.

    https://images.financialmodelingprep.com/news/what-to-know-about-buying-penny-stocks-on-june-20220629.jpg
    What to Know About Buying Penny Stocks on June 29th

    pennystocks.com

    2022-06-29 07:00:00

    Here's what you need to know about buying penny stocks on June 29th The post What to Know About Buying Penny Stocks on June 29th  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/what-to-know-about-buying-penny-stocks-on-june-20220609.jpg
    What to Know About Buying Penny Stocks on June 9th

    pennystocks.com

    2022-06-09 07:00:00

    Here's what you need to know about trading penny stocks today The post What to Know About Buying Penny Stocks on June 9th  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/trending-penny-stocks-to-watch-in-early-june-2022-20220603.jpg
    Trending Penny Stocks to Watch in Early June 2022

    pennystocks.com

    2022-06-03 19:16:53

    Check these 3 penny stocks out for your watchlist right now The post Trending Penny Stocks to Watch in Early June 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/best-penny-stocks-to-buy-in-may-3-to-20220512.jpg
    Best Penny Stocks to Buy in May? 3 to Watch Right Now

    pennystocks.com

    2022-05-12 16:12:20

    Are these 3 penny stocks on your watchlist right now? The post Best Penny Stocks to Buy in May?

    https://images.financialmodelingprep.com/news/alna-stock-alert-5-things-to-know-as-littleknown-20220512.jpg
    ALNA Stock Alert: 5 Things to Know as Little-Known Allena Pharmaceuticals Soars 100%

    investorplace.com

    2022-05-12 10:41:21

    Allena Pharmaceuticals (ALNA) stock is rocketing higher on heavy trading Thursday despite a lack of news from the company. The post ALNA Stock Alert: 5 Things to Know as Little-Known Allena Pharmaceuticals Soars 100% appeared first on InvestorPlace.

    https://images.financialmodelingprep.com/news/what-to-know-about-trading-penny-stocks-on-monday-20220509.jpg
    What to Know About Trading Penny Stocks on Monday, May 9th

    pennystocks.com

    2022-05-09 08:00:00

    Here's what you need to know about trading penny stocks on May 9th The post What to Know About Trading Penny Stocks on Monday, May 9th  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/why-are-allena-pharma-shares-plunging-today-20220321.jpg
    Why Are Allena Pharma Shares Plunging Today

    benzinga.com

    2022-03-21 09:48:03

    An independent data safety monitoring board (DSMB) has conducted the first of two planned Sample Size Reestimations (SSR1) of Phase 3 URIROX-2 Trial of Allena Pharmaceuticals Inc's (NASDAQ: ALNA) reloxaliase for enteric hyperoxaluria. Hyperoxaluria increases the risk of.

    https://images.financialmodelingprep.com/news/allena-pharmaceuticals-a-double-or-more-or-kaput-in-20220108.jpg
    Allena Pharmaceuticals: A Double [Or More] Or Kaput In The Next 90 Days

    seekingalpha.com

    2022-01-08 00:36:25

    Allena Pharmaceuticals: A Double [Or More] Or Kaput In The Next 90 Days

    https://images.financialmodelingprep.com/news/allena-stock-is-surging-in-premarket-today-as-it-20220104.jpg
    Allena Stock Is Surging In Premarket Today As It Explores Strategic, Financing Alternatives

    benzinga.com

    2022-01-04 06:24:25

    Allena Pharmaceuticals Inc (NASDAQ: ALNA) posted data from the first cohort of the Phase 2 trial (Study 201) evaluating ALLN-346 for hyperuricemia and gout in advanced chronic kidney disease (CKD). The data demonstrated a statistically significant reduction in serum uric acid (sUA) from baseline (p

    https://images.financialmodelingprep.com/news/allena-pharmaceuticals-stock-alna-why-the-price-surged-today-20220104.jpg
    Allena Pharmaceuticals Stock (ALNA): Why The Price Surged Today

    pulse2.com

    2022-01-04 06:18:41

    The stock price of Allena Pharmaceuticals Inc (NASDAQ: ALNA) increased by over 55% pre-market today. This is why it happened.

    https://images.financialmodelingprep.com/news/allena-pharmaceuticals-inc-alna-may-find-a-bottom-soon-heres-20211122.jpg
    Allena Pharmaceuticals, Inc. (ALNA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

    zacks.com

    2021-11-22 11:30:23

    Allena Pharmaceuticals, Inc. (ALNA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

    https://images.financialmodelingprep.com/news/after-plunging-197-in-4-weeks-heres-why-the-20211122.jpg
    After Plunging 19.7% in 4 Weeks, Here's Why the Trend Might Reverse for Allena Pharmaceuticals, Inc. (ALNA)

    zacks.com

    2021-11-22 11:30:18

    The heavy selling pressure might have exhausted for Allena Pharmaceuticals, Inc. (ALNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.